These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of cardiac glycosides on the duration of systole. A comparison between proscillaridin and strophanthin]. Heierli C, Schweizer W, Burkart F. Schweiz Med Wochenschr; 1971 May 08; 101(18):638-42. PubMed ID: 5103642 [No Abstract] [Full Text] [Related]
3. [Clinical pharmacology of corglycon]. Vinogradov AV, Kisra-Khaddad MM, Tsibekmakher TD. Kardiologiia; 1971 Feb 08; 11(2):70-6. PubMed ID: 5105986 [No Abstract] [Full Text] [Related]
4. [Principles and directives for practical treatment with cardiac glycosides]. Dörffel EF. Z Arztl Fortbild (Jena); 1971 Mar 01; 65(5):237-44. PubMed ID: 4997296 [No Abstract] [Full Text] [Related]
11. [Clinical experimental studies with the heart glycoside, proscillaridin, with special reference to its enteral resorption rate]. Belz GG. Med Klin; 1968 Jan 19; 63(3):96-102. PubMed ID: 5691836 [No Abstract] [Full Text] [Related]
12. [ECG studies of the resorption quota of the heart affecting glycosides]. Schellhorn W, Kaltenbach M. Med Klin; 1969 May 02; 64(18):832-6. PubMed ID: 5814962 [No Abstract] [Full Text] [Related]
17. [Assessment of the effectiveness of treating patients with mitral stenosis and fibrillation with different glycosides according to findings concerning the phase structure of right and left ventricular systole]. Epshteĭn EE, Kunitsa LD, Rogova RD. Kardiologiia; 1972 Dec 02; 12(12):111-2. PubMed ID: 4676887 [No Abstract] [Full Text] [Related]
18. [On the combined use of adonis vernalis with cardiac glycosides and strophanthin derivatives in treating patients with circulatory insufficiency]. Gubergrits AIa, Leshchinskiĭ LA. Sov Med; 1968 Jan 02; 31(1):23-7. PubMed ID: 5691025 [No Abstract] [Full Text] [Related]